Atropine eye drops serve several distinct purposes in eye care, from slowing nearsightedness in children to dilating pupils for exams and treating painful eye inflammation. The drops work by blocking receptors in the muscles of the iris and the focusing muscle inside the eye, which relaxes both. This causes the pupil to widen and temporarily prevents the eye from focusing up close. That combination of effects makes atropine useful across a surprisingly wide range of situations.
Slowing Nearsightedness in Children
The fastest-growing use of atropine eye drops is managing myopia (nearsightedness) in children. When given nightly at bedtime in very low concentrations over two to three years, atropine can meaningfully slow the rate at which a child’s vision worsens. The American Academy of Ophthalmology recommends considering low-dose atropine for children between ages 5 and 18.
The effect depends on the concentration. Full-strength 1% atropine slows myopia progression by over 70%, but the side effects at that dose (blurred near vision, light sensitivity) make it impractical for daily use. Lower concentrations strike a better balance. A 0.05% solution reduced progression by about 67%, while 0.025% reduced it by roughly 43%. The lowest commonly studied dose, 0.01%, still showed a statistically significant slowing effect, though less than the others. In a two-year study, 0.05% atropine cut new cases of myopia by nearly 50%, outperforming the 0.01% concentration.
These drops don’t reverse nearsightedness that already exists. They slow the elongation of the eyeball that drives worsening prescriptions during childhood. The goal is to reduce the degree of myopia a child ends up with as an adult, since higher levels of nearsightedness carry greater risk of retinal problems later in life.
Dilating Pupils for Eye Exams
Atropine is one of the strongest pupil-dilating drops available. Eye care providers use it to get a wide, stable view of the inside of the eye and to temporarily paralyze the focusing muscle, a state called cycloplegia. With the focusing muscle disabled, the doctor can measure the eye’s true refractive error without the lens shifting and skewing the reading. This is especially important in young children, whose powerful focusing muscles can mask the actual prescription.
A single application of 1% atropine reaches full pupil dilation in about 40 minutes, with maximum cycloplegia within roughly 5 hours. The trade-off is how long it lingers. Significant pupil dilation lasts at least 6 to 8 hours, but the pupil may not return to its normal size for up to 12 days. The focusing muscle recovers faster, typically within 1 to 3 days, though full accommodation can take up to 18 days to normalize. Because of this prolonged effect, shorter-acting drops like cyclopentolate or tropicamide are more commonly used for routine exams. Atropine is reserved for situations where the strongest possible cycloplegia is needed.
Treating Eye Inflammation
In anterior uveitis, the colored part of the eye (the iris) and surrounding structures become inflamed. This causes intense pain, light sensitivity, and a serious complication: the inflamed iris can stick to the lens behind it, forming adhesions called synechiae. These adhesions can block fluid drainage inside the eye and lead to further problems.
Atropine 1% drops address this in two ways. First, they relax the spasming ciliary muscle and iris sphincter, which directly relieves pain and light sensitivity. Second, by keeping the pupil dilated, they physically pull the iris away from the lens, preventing adhesions from forming or breaking ones that have already started. At the 1% concentration, a single dose can keep the pupil dilated for up to two weeks, which reduces how often the drops need to be applied during an active flare.
Treating Lazy Eye in Children
Atropine drops offer an alternative to eye patching for amblyopia, commonly called lazy eye. The concept is simple: a drop of 1% atropine placed in the stronger eye blurs its near vision, forcing the brain to rely on the weaker eye. This is called penalization therapy.
A large clinical trial by the Pediatric Eye Disease Investigator Group compared daily atropine to six hours of patching in children ages 3 to 7 with moderate amblyopia. Both treatments produced similar improvements in vision, though patching worked faster. Later studies found that using atropine only on weekends delivered results comparable to daily use, making it even more convenient.
For many families, atropine is the more practical option. Once the drop is placed, it works whether the child cooperates or not. Patching, by contrast, requires a child to tolerate wearing a patch for hours, which can cause significant stress and resistance. In parental surveys, atropine consistently scored higher for acceptability. The main drawback is that its effects aren’t immediately reversible. If the drop causes problems, blurring in the treated eye persists for one to two weeks after stopping.
Side Effects and Risks
The most obvious side effects of atropine are the intended ones taken too far: sensitivity to bright light from the dilated pupil and blurry near vision from the paralyzed focusing muscle. At low doses used for myopia control (0.01% to 0.05%), these effects are mild enough that most children tolerate them well, especially since the drops are given at bedtime.
At higher concentrations, the medication can be absorbed into the bloodstream and cause systemic effects. These include a fast or pounding heartbeat, dry mouth and skin, and flushing of the face and neck. These reactions are uncommon but more likely in smaller children, who have less body mass to buffer the absorbed drug. Applying gentle pressure to the inner corner of the eye after instilling the drop helps reduce drainage into the nose and throat, limiting how much enters the bloodstream.
Atropine poses a specific risk for people with narrow drainage angles in their eyes. By dilating the pupil, the drop can push the iris into a position that blocks the eye’s internal fluid outflow, triggering a sudden spike in eye pressure known as acute angle-closure glaucoma. People at higher baseline risk include older adults, women, and individuals of Asian, Inuit, or Hispanic descent. Anatomical features like a shallow front chamber of the eye or a shorter-than-average eyeball also increase susceptibility. Eye care providers typically check angle anatomy before prescribing atropine to rule out this risk.
How Atropine Compares to Other Dilating Drops
Several other drops dilate the pupil or paralyze focusing, but atropine stands apart for its potency and duration. Tropicamide, the most commonly used dilating drop, wears off within 4 to 8 hours. Cyclopentolate lasts roughly 24 hours. Atropine’s effects persist for 7 to 12 days. This makes it the wrong choice when you just need a quick look inside the eye during a routine appointment, but the right one when sustained dilation or deep cycloplegia is the goal, such as in pediatric refraction, uveitis management, or amblyopia treatment.
For myopia control specifically, atropine is the only eye drop with strong clinical evidence supporting long-term use. Other myopia management strategies exist, including specially designed contact lenses and glasses, but atropine remains one of the most studied and widely adopted options worldwide.